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ABSTRACT
Fetal perturbations in DNA methylation during lung development may reveal insights into the enduring impacts
on adult lung health and disease during aging that have not been explored altogether before.
We studied the association between genome-wide DNA-methylation and post-conception age in fetal-lung
(n=78, 42 exposed to in-utero-smoke (IUS)) tissue and chronological age in adult-lung tissue (n=160, 114 with
Chronic Obstructive Pulmonary Disease) using multi-variate linear regression models with covariate adjustment
and tested for effect modification by phenotypes. Overlapping age-associations were evaluated for functional
and tissue-specific enrichment using the Genotype-Tissue-Expression (GTEx) project.
We identified 244 age-associated differentially methylated positions and 878 regions overlapping between fetal
and adult-lung tissues. Hyper-methylated CpGs (96%) were enriched in transcription factor activity (FDR
adjusted P=2x10-33) and implicated in developmental processes including embryonic organ morphogenesis,
neurogenesis and growth delay. Hypo-methylated CpGs (2%) were enriched in oxido-reductase activity and
VEGFA-VEGFR2 Signaling. Twenty-one age-by-sex and eleven age-by-pack-years interactions were statistically
significant (FDR<0.05) in adult-lung tissue.
DNA methylation in transcription factors during development in fetal lung recapitulates in adult-lung tissue
with aging. These findings reveal molecular mechanisms and pathways that may link disrupted development in
early-life and age-associated lung diseases.

INTRODUCTION
DNA methylation represents an epigenetic mark with a
critical role in early life development and aging [1]
that differs across tissues [2]. Previous studies in
ageing research have emphasized adulthood, however
increasing evidence has highlighted that ageassociated cognitive decline as well as adverse later
life health outcomes, for example, depend largely on
epigenetic programming or adaptations during fetal
development [3]. With the complex reprogramming
during early-life stages, interplay of dynamic DNA
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methylation, chromatin marks and environmental
effects during the life course make it further
complicated to identify age-related versus cumulative
life-course manifestations of the genome [4, 5].
Prenatal and lifetime exposures have a tremendous
impact on both short- and long-term consequences
mediated through epigenetic mechanisms and may
contribute to a broad spectrum of immune responses,
respiratory, cardiovascular and age-related diseases in
later life [6, 7]. Evidence suggests impact of hypo- and
hyper-methylation [8] including an altered epigenetic
state on several age-associated neurological functions
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and human disease [9]. A recent meta-analysis
identified several novel age-associated differentially
methylated CpG sites in newborns and children
reflective of processes critical to development [10].
Further efforts have identified the role of sex [11] and
race-specific [12] differential methylation in blood
along the aging process or associated pathologies.
Fetal tissue DNA methylation changes associated with
post-conception age and sex have been suggested to
reflect brain development and are supportive of the
idea that aging processes start early in life [13].
Previously, strong tissue-specific age associations with
DNA methylation and gene expression have been
identified in fetal and adult human livers [14],
however, there is a paucity of previously reported
tissue-specific studies in the literature and none for
lung. Therefore, identifying more accurate biomarkers
in lung tissue may merit further investigation to
identify individuals at risk for age-associated lung
function decline.
Recent studies have identified DNA methylation at
selected CpGs to strongly predict chronological [15–
21] age, constituting the epigenetic clock [21]. This
may be especially useful to identify or differentiate
individuals at the greatest risk for age-related health
disparities and conditions. There is also a growing
interest in understanding the role of epigenetic age
acceleration or deceleration during the intrauterine
period and adulthood. A significant association was
observed between prenatal exposure to tobacco smoke
and the risk of accelerated aging at birth [22],
suggestive of developmental effects during childhood
and the biomarker potential of age acceleration in
adulthood [23]. However, limited agreement with low
to moderate correlations have been observed between
different epigenetic clocks estimating biological age
owing to the various aspects captured by them
including mortality risk, smoking, lifespan and time to
death [21, 24].
To our knowledge, epigenetic links between fetal
lung development and age-associated epigenetic
marks in adult lung tissue (including DNA
methylation age) have not been extensively explored.
In this study, we performed a comparative analysis
of age associated differential methylation and DNA
methylation age in fetal and adult lung tissues and
evaluated effect modification of age associations as a
marker of development by sex and smoke exposure.
Given that chronic lung diseases may be impacted by
both altered lung development and accelerated aging
processes, investigating age associated DNA
methylation may inform new insights into lung
diseases of aging, including chronic obstructive lung
disease (COPD).
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RESULTS
Age-associated differential methylation in fetal and
adult lung tissues
The IUS-exposed and unexposed samples did not differ
by mean gestational age of the percentage of males and
females in the fetal lung dataset (Table 1). 94,834 CpGs
(27.1%) were significantly associated with fetal age
(FDR <0.05; Supplementary Table 1, Figure 1,
Supplementary Figure 1) and 35,846 (10.3%) ageassociated differentially methylated positions (aDMPs)
remained at a Bonferroni significance threshold
(P<1.43x10-7). Of the 94,834 CpGs, 40,836 sites were
relatively hypo-methylated and 53,998 sites were
relatively hyper-methylated with increasing age
(Supplementary Figure 2A) and were strongly enriched
in gene body and 3’UTRs (Hypergeometric
P-Value<2.2x10-16, P-Value=5.4x10-62 respectively)
regions. Of the top 20 significant age-associated DMPs,
11 were located in CpG shores and their top associated
genes included C17orf96 and CASZ1 (Table 2A).
Twelve CpGs were also significantly associated with
age at an absolute difference in methylation of at least
1% and with most sites increasing in methylation with
age; their top associated genes included IGFBP1 and
MEGF11 (Supplementary Figure 2A). In our fetal lung
aDMPs, we also found previously discussed
differentially methylated age-associations identified in
fetal brain tissue [13] including SFRP1, NR4A2 and
SHANK2.
In the adult lung tissue (ALT) dataset, COPD subjects
differed from subjects without COPD by time since
quitting cigarette smoking (in months), LAA-950 and
pack-years but did not differ by age (Table 1). We
identified 2,217 (0.7%) significant aDMPs (FDR <0.05,
Supplementary Table 2, Figure 1). Of those, 2,181 were
relatively hyper-methylated and 36 were relatively
hypo-methylated with increasing age and a maximum
absolute effect size of 0.7% per year (Supplementary
Figure 2B). These aDMPs were strongly enriched
for
transcription
start
sites
(Hypergeometric
P-Value=2.1x10-31). The top 20 significant ageassociated DMPs were mostly located in CpG islands;
their top associated genes included DLL3 and PRDM2
(Table 2B). Two sites, cg16867657 (regression
coefficient: 0.004, FDR adjusted P=3.8x10-9) and
cg24724428 (regression coefficient: 0.006, FDR adjusted
P=3.8x10-9) annotated to ELOVL2 gene, a biomarker of
age [25] and also the top gene based on effect size in the
adult lung data (Supplementary Figure 2B).
From the aDMPs identified in the adult lung dataset,
244 CpGs (11% of the differentially methylated loci)
that mapped to 144 unique genes (13.7% of the unique
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Table 1. Overall clinical characteristics in fetal and adult lung tissue (ALT) datasets.
Fetal lung tissue (n=78)

Post-Conception Age (days), mean (SD)
Chronological Age (years), mean (SD)
DNAmAge (years), mean (SD)
Age Acc. difference, mean (SD)
Age Acc. residual, mean (SD)
Sex, n (%)
Female
Male
Adult lung tissue (n=160)

Age (years), mean (SD)
DNAmAge (years), mean (SD)
Age Acc. difference, mean (SD)
Age Acc. Residual, mean (SD)
Sex, n (%)
Female
Male
Race, n (%)
African American
White
Others
Time since quitting (months), mean (SD)
LAA-950, mean (SD)
Pack-years

All subjects
(n = 78)
88.7 (16)
-0.50 (0.04)
0.50 (0.30)
0.99 (0.27)
0.00 (0.20)

IUS-Exposed
(n = 42)
86 (16.4)
-0.50 (0.04)
0.41 (0.28)
0.92 (0.25)
-0.04 (0.17)

Unexposed
(n = 36)
91.9 (15.2)
-0.49 (0.04)
0.60 (0.30)
1.08 (0.27)
0.05 (0.21)

28 (36)
50 (64)

16 (38)
26 (62)

12 (33)
24 (67)

All subjects
(n = 160)
63.9 (7.4)
66.8 (6.6)
2.8 (5.1)
0.00 (4.5)

With COPD
(n = 114)
63.4 (6.7)
66.4 (6.2)
3 (4.4)
0.01 (4)

Without COPD
(n = 46)
65.3 (8.9)
67.7 (7.4)
2.3 (6.7)
-0.04 (5.5)

89 (56)
71 (44)

60 (53)
54 (47)

29 (63)
17 (37)

P-value
0.1
0.1
8.1x10-3
7.1x10-3
0.03
0.84

P-value
0.19
0.33
0.50
0.96
0.31

0.78
25 (16)
131 (81.9)
4 (2.5)
112 (113)
0.3 (0.2)
53.3 (27.8)

19 (17)
92 (80.7)
3 (2.6)
181 (139.9)
0.3 (0.1)
61.2 (26.4)

6 (13)
39 (84.8)
1 (2.2)
84.7 (87.2)
0.0 (0.1)
33.6 (20.5)

6.7x10-5
<2.2x10-16
1.6x10-10

Significance of difference was evaluated using two-sample t-test for continuous variables and chi-squared test for categorical
variables except race where fisher test was used due to smaller number of samples in individual categories. Missing data:
Time since quitting data (months) was missing for 1 subject without COPD, fraction of lung voxels with low attenuation areas
at less than -950 Hounsfield Units (LAA-950) was missing for 27 subjects without COPD and 28 COPD subjects.
Abbreviations: SD, standard deviation; n, number of subjects; DNAmAge, DNA methylation or epigenetic age; Acc.,
Acceleration.

differentially methylated genes) overlapped with the
fetal lung age-EWAS (Supplementary Table 3). The
corresponding findings from the analysis stratified by
IUS-exposure and COPD status in fetal and adult lung
datasets for these 244 CpGs have been included in
Supplementary Table 3. In the fetal lung dataset, the
effect estimates for 238 CpGs from the non-IUSexposed and all 244 CpGs from the IUS-exposed
samples only analysis were in the same direction to the
effect estimates of the 244 overlapping aDMPs from the
overall fetal lung analysis. In the ALT dataset, 243
CpGs from the non-COPD subjects only and all 244
CpGs from the COPD case-only analysis were in the
same direction of effect to the effect estimates of the
244 overlapping aDMPs from the overall ALT analysis
(Supplementary Table 3).
www.aging-us.com
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The top 20 annotated CpGs were associated with nine
transcription factors: EVX1, HIF1A, ALX3, SATB2,
PITX2, NKX2-4, ZIC1, ZIC2, BSX and are presented in
Table 2C. Of those 244 CpGs, 215 had effect estimates
in the same direction (210 hyper- and five hypomethylated) including the CpG site cg16867657 mapped
to the promoter of ELOVL2 gene. The methylation
patterns for cg16867657 were progressively hypermethylated with age for both the fetal and adult lung
datasets (Supplementary Figure 3A, 3B).
Considering aging may have a genetic component, we
had further investigated the presence of methylation
quantitative trait loci (mQTLs) among the overlapping
244 aDMPs using the previously published methylation
lung tissue QTL results [26]. Sixty-three (25.8%) and 17
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(7%) of the 244 aDMPs in both fetal and adult lung
datasets overlapped with the 1,787 significant cis mQTLs
(located within 1 Mb of a specific CpG site) and 133
significant trans mQTLs (located beyond 1 Mb of a
specific CpG site or on different chromosomes) at an
FDR < 0.05 (Supplementary Table 4) which provide
evidence for genetically influenced aDMPs. Interestingly,
among the overlap with cis-mQTLs, the top gene based
on significance was FADS2; its associated
polymorphisms modulate fatty acid metabolism [27] and
influence asthma risk [28]. However, the smaller overlap
with mQTLs suggests that majority of our age
associations (67.2%) were not genetically driven.
The regional analysis in fetal and adult lung datasets
resulted in 14,427 and 270 significant regions
(FDR<0.05) respectively with an overlap of three
regions by exact chromosomal coordinates and 878
regions (Supplementary Table 5) by overlapping genes.
Two of those regions with exact overlap of chromosomal
coordinates mostly mapped to small nucleolar RNAs
(snoRNAs/SNORA) and small cajal body-specific RNAs
(scaRNAs/SCARNA) family genes, while the third
region could not be mapped to any genes.

Effect modification of age-associated methylation by
smoke exposure and sex
In the fetal lung data, the interaction between
gestational age and exposure to cotinine (continuous
variable) resulted in 11,810 differentially methylated
CpGs (P<0.05); none were robust to adjustment at an
FDR of 5% (FDR<0.05) or less stringent threshold of
10% (FDR<0.10) but many passed at a nominal P-value
of 0.05 (Supplementary Table 6). This is consistent with
the modest findings from our prior IUS “main effects”
analysis [29]. Interaction between gestational age and
sex revealed three CpGs. relatively hyper-methylated
with age in males compared to females (FDR<0.10,
Supplementary Table 7).
In the adult lung data, the interaction of chronological
age with time since smoking cessation resulted in one
differentially methylated CpG site mapped to the
DSCC1 gene (cg21745419; regression coefficient
=3.3x10-6; FDR adjusted P=3.9x10-3). The interaction
between age and pack-years resulted in 10 differentially
methylated CpGs significant at an FDR threshold
of 0.05 (Supplementary Table 8). One CpG site:

Figure 1. Manhattan plot depicting significance on y-axis and distribution of CpGs across all chromosomes on x-axis for fetal
lung dataset (top panel) and adult lung dataset associations with age (bottom panel). Top 20 CpGs in both datasets have been
highlighted in green. The two red lines represent the CpG sites significant at an FDR<0.05 and at a Bonferroni threshold (0.05/number of tests)
in fetal and adult lung datasets.
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Table 2A. Age-associated differential methylation in the fetal lung tissue datasets.
CG site

UCSC Gene CHR

MAPINFO

Island

cg14651082

NA

12

125,145,939

S_Shore

cg00964751

C17orf96

17

36,828,900

N_Shore

cg01821043

CASZ1

1

10,766,044

S_Shore

cg03955927 LOC100132215

2

63,272,232

cg05457903

PLEC1

8

cg03389701

DLEU7

cg25133130

MAP3K6

cg09018299
cg24025567

Gene
context

Coef

AveBeta P-Value Adjusted P

0.004

0.26

1.67E-37

5.82E-32

1stExon

0.005

0.32

9.66E-37

1.55E-31

5'UTR

0.005

0.60

2.09E-36

1.55E-31

Island

Body

0.007

0.66

2.19E-36

1.55E-31

145,052,304

Island

TSS1500

0.004

0.28

2.23E-36

1.55E-31

13

51,418,221

S_Shore

TSS1500

0.004

0.47

5.03E-36

2.93E-31

1

27,687,685

Island

Body

0.004

0.43

1.79E-35

8.93E-31

TNRC6A

16

24,748,339

OpenSea

Body

-0.006

0.72

4.01E-35

1.75E-30

CUX1

7

101,505,662

OpenSea

Body

0.003

0.47

6.38E-35

2.31E-30

cg11067714

PURA

5

139,492,230

N_Shore

TSS1500

0.006

0.34

6.74E-35

2.31E-30

cg14205663

NR2F2

15

96,872,827

N_Shore

TSS1500

0.005

0.29

7.48E-35

2.31E-30

cg25903143

NA

11

68,920,466

OpenSea

0.006

0.25

8.33E-35

2.31E-30

cg11654900

NA

1

51,444,685

S_Shore

0.009

0.26

8.58E-35

2.31E-30

cg13803234

RAD51L1

14

68,830,813

OpenSea

Body

0.005

0.50

9.65E-35

2.38E-30

cg00079023

PURA

5

139,492,535

N_Shore

TSS1500

0.003

0.18

1.02E-34

2.38E-30

cg10681992

TBC1D14

4

6,964,527

OpenSea

Body

0.004

0.62

1.62E-34

3.53E-30

cg05878390

MAB21L2

4

151,502,935

N_Shore

TSS200

0.007

0.23

2.36E-34

4.84E-30

cg19791727

NA

10

21,798,015

Island

0.008

0.55

2.57E-34

4.84E-30

cg22783327

FXYD1

19

35,633,258

N_Shore

Body

0.006

0.30

2.71E-34

4.84E-30

cg06519422

GABBR1

6

29,599,226

N_Shore

Body

0.004

0.46

2.82E-34

4.84E-30

Top 20 significant differentially methylated CpGs associated with age in the fetal lung data set. P-values were adjusted by the
Benjamini-Hochberg method to correct for multiple testing.
Abbreviations: UCSC, The University of California Santa Cruz; Coef, regression coefficient - Adjusted mean difference (per day
increase or decrease) in methylation with age. NA: un-annotated CpG site; CHR, chromosome; AveBeta, average beta; P, p-value.

cg10682155 mapped to the SIM2 gene and overlapped
with the nominal age by exposure associations in fetal
lung (Supplementary Table 7). Interaction of age with
sex resulted in 47 significant differentially methylated
sites (FDR<0.10, Supplementary Table 8); 21 of those
CpG sites were also significant at an FDR threshold of
0.05. Interestingly, cg24724428 mapped to the ELOVL2
gene promoter and also demonstrated age-by-sex
associations (regression coefficient=0.007; FDR adjusted
P=0.06). This CpG was 10 bases upstream of the ageassociated ELOVL2 CpG site cg16867657. These
analyses demonstrated potential methylation effect
modification with age by both sex and smoke exposure in
fetal and ALT datasets.
CpGs associated with age
transcription factor pathways

are

enriched

in

Genes annotated to hyper-methylated aDMPs in both
fetal and adult lung tissue datasets had the most
significant enrichment for RNA polymerase II-specific
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DNA-binding transcription factor activity (FDR adjusted
P=2.0x10-33; 52 genes; Supplementary Table 9, Figure
2A). Genes annotated to hypo-methylated aDMPs were
mainly enriched (FDR<0.05, Figure 2B) for Cell Cycle
(PRKCA, NCAPD3), oxidoreductase activity (ALDH4A1,
PDIA6) and VEGFA-VEGFR2 signaling pathway
(PRKCA, PDIA6), however this analysis may have been
limited due to the small number of genes represented by
few overlapping hypo-methylated aDMPs between both
datasets. Most enriched biological processes in the
overlapping aDMPs between fetal and ALT included
terms related to development including embryonic organ
morphogenesis, neurogenesis and growth delay. Two
enriched wiki-pathways were identified: Neural Crest
Differentiation annotated with five genes (ZIC1, HAND1,
OLIG3, ZIC5, PAX3) and Mesodermal Commitment
Pathway annotated with six genes (PITX2, ZIC2,
HAND1, PAX6, ZIC5, SOX21).
The 125 genes with age associations in the same
direction in both fetal and ALT datasets were further
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Table 2B. Age-associated differential methylation in the adult lung tissue dataset.
CG site
cg07640648
cg26830108
cg02650266
cg05024939
cg23813012
cg05617798
cg21186299
cg23606718
cg27320127
cg16477091
cg10806820
cg12373771
cg16867657
cg24724428
cg01763090
cg15906794
cg02383785
cg05991454
cg07544187
cg03036557

UCSC
Gene
DLL3
NA
NA
NA
PRDM2
AURKB
VGF
AMER3
KCNK12
PPM1E
CELSR3
CECR6
ELOVL2
ELOVL2
OTUD7A
YBX2
NA
NA
CILP2
GPC5

CHR

MAPINFO

Island

Gene context

Coef

AveBeta

19
7
4
4
1
17
7
2
2
17
3
22
6
6
15
17
7
4
19
13

39,993,697
100,813,299
147,558,239
113,442,251
14,026,482
8,113,714
100,808,810
131,513,927
47,798,396
56,833,000
48,699,090
17,601,381
11,044,877
11,044,888
31,775,406
7,197,963
127,808,848
147,558,435
19,651,235
92,050,720

Island
N_Shelf
Island
N_Shore
Island
Island
Island
Island
Island
Island
Island
Island
Island
Island
N_Shore
Island
Island
Island
Island
N_Shore

Body

0.001
0.002
0.003
0.002
0.002
0.001
0.001
0.003
0.003
0.002
0.003
0.003
0.004
0.006
0.002
0.004
0.003
0.003
0.004
0.002

0.04
0.07
0.13
0.26
0.10
0.07
0.03
0.24
0.22
0.15
0.22
0.22
0.74
0.26
0.12
0.17
0.22
0.12
0.15
0.07

TSS1500
5'UTR
1stExon
5'UTR
TSS1500
TSS1500
1stExon
1stExon
TSS1500
TSS1500
3'UTR
TSS200

Body
TSS1500

P-Value Adjusted P
1.15E-14
7.02E-15
2.73E-14
3.35E-14
2.70E-14
6.07E-14
6.73E-14
5.61E-14
4.54E-14
8.06E-14
9.47E-14
1.25E-13
1.49E-13
1.50E-13
1.89E-13
2.84E-13
3.68E-13
5.58E-13
6.05E-13
1.79E-12

2.00E-09
2.00E-09
2.34E-09
2.34E-09
2.34E-09
2.61E-09
2.61E-09
2.61E-09
2.61E-09
2.82E-09
3.01E-09
3.65E-09
3.76E-09
3.76E-09
4.40E-09
6.22E-09
7.57E-09
1.08E-08
1.11E-08
3.13E-08

Top 20 significant and differentially methylated CpGs associated with age in the adult lung tissue dataset. P-values were
adjusted by the Benjamini-Hochberg method to correct for multiple testing.
Abbreviations: UCSC, The University of California Santa Cruz; Coef, regression coefficient - Adjusted mean difference (per year
increase or decrease) in methylation with age. NA: un-annotated CpG site; CHR, chromosome; AveBeta, average beta; P, pvalue.

assessed for gene-based enrichment analysis and
functional relevance in gene-sets using tissue-specific
expression in 54 tissue types from the GenotypeTissue Expression project (GTEx) v8 [30]. Among the
tissue-specific gene-sets, the strongest enrichment for
hyper-methylated CpGs was observed among the
down-regulated genes in the lung; up-regulated genes
were noted for brain regions but not for lung (Figure
2C, Supplementary Table 10). Among the curated
gene-sets and transcription factor targets obtained
from MsigDB, the strongest enrichment was for polycomb regulated genes in human embryonic stem cells,
predominantly H3K27me3 and transcription factor
binding sites respectively (Supplementary Figure 4A,
4B). The most enriched transcription factor target
gene-set included PAX6, HOXC4, FOXG1, SALL3,
TBR1, DLX1, ZIC4, ZIC1, SHOX2, ATOH1, PITX2
and OLIG3 (Supplementary Figure 4C) with hypermethylated CpGs in our findings. There was no tissuespecific or gene set enrichment observed for genes
annotated to hypo-methylated CpGs, likely due to
small numbers. Gene associations for the significant
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differentially methylated regions also had the most
significant enrichment for RNA polymerase II
transcription factor activity/sequence-specific DNA
binding (Supplementary Table 11) with a significant
percentage of those within 5kb of transcription start
site for both fetal and ALT datasets (Figure 2D, 2E).
Measures of epigenetic age acceleration in fetal and
adult lung tissues
We did not identify a large overlap between the 353
Horvath clock markers and our differentially
methylated age EWAS associations. Of the 353 CpG
clock markers, 91 markers existed within the fetal
lung aDMPs and 17 within the adult lung aDMPs and
two CpGs (cg12946225: HMG20B; cg23517605:
TUBB2B) were common to all three comparisons.
Our EWAS quality control processing pipeline filtered
out some of those 353 clock markers, however
the smaller overlap may also suggest a different
subset of age associations captured between the
models.
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Table 2C. Age-associated differential methylation in the fetal and adult lung tissue datasets.
Fetal lung
CG site

Adult lung

CHR

MAPINFO

UCSC Gene

Context

Avebeta

Coef

Coef

Adjusted P

Direction

cg22296612

6

15,457,699

JARID2

Body

0.92

0.002

3.60E-15

0.99

-0.0001

0.016

+-

cg17110767

1

243,637,966

SDCCAG8

Body

0.67

0.003

cg20801476

7

27,281,465

EVX1

TSS1500

0.06

0.001

4.24E-13

0.97

0.001

0.014

++

5.27E-13

0.24

0.001

0.048

++

cg20580088

14

62,161,583

HIF1A

TSS1500

0.13

0.001

2.28E-12

0.28

0.002

0.012

++

cg17611674

10

8,094,431

FLJ45983

Body

0.10

0.001

2.34E-12

0.38

0.002

0.020

++

cg24388061

8

141,249,678

TRAPPC9

cg21595709

19

15,344,186

EPHX3

Body

0.73

0.002

7.82E-12

0.94

0.001

0.008

++

TSS1500

0.05

0.001

2.90E-11

0.21

0.001

0.039

++

cg00484358

1

110,610,995

ALX3

Body

0.12

0.001

1.07E-10

0.38

0.001

0.039

++

cg27583307

2

200,320,750

SATB2

Body

0.03

0.000

2.35E-10

0.11

0.001

0.049

++

cg03470772

4

cg20992114

4

85,503,328

CDS1

TSS1500

0.03

0.000

4.48E-10

0.26

0.002

0.028

++

111,542,825

PITX2

Body

0.08

0.001

7.98E-10

0.28

0.001

0.002

++

cg07247419

20

21,376,484

NKX2-4

3'UTR

0.02

0.000

1.45E-09

0.24

0.002

0.007

++

cg22197050

2

63,276,183

0.03

0.000

5.83E-09

0.27

0.002

0.000

++

cg06306198

3

147,128,998

ZIC1

cg11814235

18

28,621,490

DSC3

Body

0.05

0.001

1.73E-08

0.23

0.001

0.042

++

Body

0.02

0.000

1.97E-08

0.12

0.001

0.031

++

cg14614094

9

133,567,903

EXOSC2

TSS1500

0.36

0.001

3.80E-08

0.69

0.002

0.015

++

cg15110296

12

12,509,705

LOH12CR1

TSS1500

0.68

-0.002

5.41E-08

0.26

-0.003

0.042

--

cg18431640
cg24719321

13

100,637,191

ZIC2

Body

0.03

0.000

1.45E-07

0.19

0.001

0.008

++

11

122,850,490

BSX

Body

0.02

0.000

1.53E-07

0.18

0.002

0.002

++

cg08376141

6

32,116,591

PRRT1

3'UTR

0.11

0.001

2.11E-07

0.53

0.003

0.003

++

LOC100132215 TSS1500

Adjusted P AveBeta

Top 20 annotated and differentially methylated age-associated DMPs overlapping between fetal lung and the adult lung tissue
dataset. P-values were adjusted by the Benjamini-Hochberg method and are sorted based on the discovery fetal lung dataset.
Abbreviations: UCSC, The University of California Santa Cruz; Coef, regression coefficient - Adjusted mean difference (per day
increase or decrease for fetal lung dataset and per year increase or decrease for adult lung tissue dataset) in methylation with
age. NA: un-annotated CpG site; CHR, chromosome; AveBeta, average beta; P, p-value.

Among the fetal lung samples, chronological age was
significantly positively correlated with the DNAmAge
as expected (cor=0.76, P=3.6x10-16, Supplementary
Figure 5A). Overall, the fetal lung sample ages
appeared epigenetically accelerated with higher age
estimates for DNA methylation age compared to
chronological age (Table 1). However, IUS-exposure
was associated with lower epigenetic age differences
when compared to epigenetic age of unexposed samples
after adjusting for available covariates, suggesting
relative developmental delay related to IUS exposure
(Estimate: -0.10; 95% CI: -0.19, -0.01; P=0.03; Table
3). In the multivariate regression model including age
and other covariates, we did not detect statistical
differences by sex although they were in the same
direction of effect as in the ALT dataset (Table 3).

Figure 5B). The COPD cases showed a trend for
accelerated aging compared to subjects without COPD
(Estimate: 2.20; 95% CI: -1.04, 5.44; P=0.18, Table 3);
however males demonstrated significant epigenetic age
acceleration compared to females that stayed robust after
adjustment with covariates in the multivariate model
(Estimate: 1.98; 95% CI: 0.13, 3.83; P=0.036, Table 3).

In the adult lung dataset, we observed significant
positive correlation between chronological age and the
DNAmAge (cor=0.74, P<2.2x10-16; Supplementary

Aging and age-associated epigenetic drift [31] in
prenatal and postnatal life drive progressive and
widespread methylation changes that can be captured by
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Investigating smoking cessation behaviors, there was a
suggestive trend for association between age acceleration
and recent smoke cessation only within females
compared to males in the multivariate model. The trend
was not significant in males, however the effect estimates
were in the same direction (Supplementary Table 12).

DISCUSSION

AGING

Figure 2. Network visualization, functional enrichment and region-gene associations in both fetal and adult lung tissue
datasets. Network clusters of the molecular function gene ontology terms and annotated pathways including reactome and wikiPathways
were created using the gene symbols mapped to the significant and age-associated differentially methylated positions (DMPs) overlapping
between fetal and adult lung datasets. (A) Hyper-methylated CpGs were mainly enriched in transcription factor DNA binding whereas
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(B) hypo-methylated CpGs were enriched in oxidoreductase activity. Size corresponds to the overlap of genes between the enriched terms
and color corresponds to significance. The analysis for hypo-methylated CpGs was limited by few numbers of genes represented by few CpGs
(C) Functional enrichment of age-associated hyper-methylated DMPs in both fetal and adult lung tissue datasets amongst differentially
expressed genes in 54 GTEx tissues (x-axis) and –log10(P-value) on the y-axis. Tissues with significant gene enrichment (FDR<0.05) are
highlighted by red bars and tissues with the highest enrichment amongst the downregulated and upregulated genes are highlighted by
arrows (D) Region-Gene associations using chromosomal coordinates for the differentially methylated regions in fetal lung dataset (E) Adult
lung tissue dataset. TSS: transcription start site.

epigenetic clocks [16], however there is no clear gold
standard [21]. Telomere shortening had long been
considered a hallmark of biological aging, however
recently weak correlation was found between telomere
length and age-associated health outcomes [32]. With
refinement in aging algorithms, ongoing efforts for
precision health initiatives aim to identify better
epigenetic biomarkers with predictive potential for
obstructive lung disease, as these may facilitate primary
interventions [33]. Our study importantly contributes to
identifying age-associated patterns of differential
methylation overlapping between early-life (fetal) and
adulthood (adult lung) implicated in crucial
developmental processes and demonstrates their effect
modification by sex and smoke-exposure. This has never
been examined before in lung tissue studies.
Rapid and considerable changes in methylation occur in
early fetal life; therefore our finding of thousands of ageassociated DMPs in fetal lung is not surprising. One of
the most interesting and encouraging global findings was
enrichment of hyper-methylated CpGs for transcription
factor activity and down-regulated genes in the lung from
GTEx gene-sets. Increased tissue-specific transcriptional
variability has been associated with age, with DNA
methylation playing an integral role in activating
or silencing a gene mediated by transcription factor
binding [34]. Evidence also suggests age-associated
hypermethylation in whole blood to occur at chromatin
promoter domains typical of transcriptional repression in
nearby neural genes [35] and those that are involved in
DNA binding and transcriptional regulation [36].
Aberrant hypermethylation and silencing of genes
required for maintenance of a differentiated state has
been observed in murine lung development and lung
cancer [37]. A 2012 healthy aging study [38] pointed out
that the age-associated DMPs and DMRs that are often
activated or deregulated early in life hinted towards
developmental defects that may not necessarily represent
healthy aging in later life and cause a wide range of
detrimental health outcomes. As an example, one of the
several transcription factors that we mentioned was ZIC1.
The tissue-specific transcription factor ZIC1 and its
family functions by binding to enhancer regions in the
developing brain and was identified as having a crucial
regulatory role in neuronal differentiation and age-related
Alzheimer's disease [39]. When looking specifically
at region-overlap, the majority of those genes included
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snoRNAs/scaRNAs. These non-coding RNAs have
gained substantial interest lately due to their clinical
relevance in various pathologies including lung cancer,
host antiviral responses and their regulatory role in RNA
modifications, splicing and telomerase activity [40].
Moreover, it was reassuring that our overlapping ageassociated DMRs between both fetal and adult lung tissue
datasets were also enriched in DNA-binding transcription
factor activity with common gene-sets, which may
represent regions of regulatory potential as well as targets
of epigenetic therapy. Of course, functional transcription
factor binding can only be confirmed via experimental
validation. However these results do suggest that
methylation changes associated with aging and
environmentally mediated exposures throughout life may
impact biological processes and pathways crucial for
growth, development and immune system regulation
during the life course. Considering directionality of
effect, most of our adult EWAS findings between both
fetal and adult lung datasets were hyper-methylated with
age which is in line with the previous findings [38]
pointing towards the methylation hotspots that are
consistently altered with age-dependent or age-related
phenotypes.
Age associated epigenetic variation may additionally
reveal genes further disrupted in age associated lung
diseases such as COPD. In our fetal lung aDMPs, we
found previously discussed differentially methylated
age-associations identified in fetal brain tissue [13]
including the Wnt antagonist SFRP1 known to be
differentially methylated in adults with asthma [41] and
previously associated with emphysema [42], nuclear
receptor gene NR4A2 crucial for neurogenesis and
SHANK2 implicated in neurodevelopmental disorders
such as autism and severe asthma [13, 43]. ELOVL2 is a
consistently identified biomarker for aging [12] further
supported by our finding of association of the agerelated ELOVL2 gene and the rapid hypermethylation of
its promoter cg16867657 [25, 44]. Interestingly, we also
identified an age-by-sex association for the ELOVL2
gene, at another nearby CpG site: cg24724428; both
these sites were significantly correlated with age in the
EWAS Atlas and in the majority of tissues [44].
Age associated enrichment of hypo-methylated sites
characterized by methylation protein binding, oxidoreductase and aldehyde dehydrogenase activity while
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Table 3. Associations between epigenetic age acceleration and lung phenotypes;
IUS-exposure and sex in fetal lung dataset and COPD status, sex, time since quitting
(in months), pack-years and fraction of lung voxels with low attenuation areas at
less than -950 Hounsfield Units (LAA-950) in the adult lung tissue dataset.
Epigenetic clock metrics in fetal and adult lung tissues
Age Acceleration
Multivariate model predictors
Fetal Lung
Estimate (95% CI)
P-value
IUS-exposure
-0.10 (-0.19, -0.01)
0.03
Sex
0.03 (-0.07, 0.12)
0.57
Adult Lung
Estimate (95% CI)
P-value
COPD
2.20 (-1.04, 5.44)
0.18
Sex
1.98 (0.13, 3.83)
0.036
months-quit
-0.01 (-0.02, 0.004)
0.21
pack-years
-0.01 (-0.05, 0.02)
0.46
LAA-950
-1.94 (-9.30, 5.43)
0.60
Multivariate models were residualized for age and were additionally adjusted for potential
confounders in both datasets. In fetal lung dataset, unexposed samples were used as
reference compared to IUS-exposed samples; covariates included post-conception/gestational
age (continuous) and sex (male or female; female as reference). In adult lung tissue dataset,
subjects without COPD were used as reference compared to COPD subjects; covariates
included chronological age, sex (male or female; female as reference), race (white, AfricanAmericans and others), pack-years (smoke exposure, continuous), LAA-950 (marker for airway
emphysema, continuous), months-quit, (time since quitting in months, continuous) and
technical covariate sample plate. DNAmAge as output from Horvath clock (in years) was used
for both datasets. Age acceleration was calculated as the difference between DNAmAge and
chronological age. Significant P-Values are highlighted as bold.
Abbreviations: CI, confidence interval.
Missing data: Time sine quitting data (months) was missing for 1 subject without COPD,
fraction of lung voxels with low attenuation areas at less than -950 Hounsfield Units (LAA-950)
was missing for 27 subjects without COPD and 28 COPD subjects.

limited with few CpGs in our study could point to
oxidative stress that can cause susceptibility to
inflammatory disorders of the airways such as asthma
and COPD. Variable methylation and expression
changes have previously linked aging, COPD [45] and
idiopathic pulmonary fibrosis (IPF) [46]. Of note,
genes in VEGFA-VEGFR2 signaling mapped to hypomethylated CpGs. The vascular endothelial growth
factor-A and its family is crucial for endothelial cell
survival and angiogenesis and its components are
known biomarkers for asthma-COPD overlap
syndrome [47]. One of the blood-based studies in lung
tissue associated smoking with site-specific hypomethylation [48]. The age-associated sites modified
by smoke exposure and smoking cessation may
further attenuate the risk of age-related lung diseases
such as COPD and IPF or may point to reversed
methylation signatures by smoking cessation over
time for fetal origins of lung disease and susceptibility
to other developmental or neurological disorders
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triggered in early life. There is also evidence
that imbalance in the redox potential mediates
inflammation, airflow limitation and airway
remodeling in asthma and COPD [49]. Cigarette
smoking is known to cause oxidative stress, disrupting
the vascular endothelial growth factor (VEGF)/VEGF
receptor (VEGFR) signaling and may promote
emphysema [49]. These findings provide mechanistic
insights into lung tissue-specific signatures of hypoand hyper-methylation with age, pointing to a
sensitive transcriptional regulation mediated by DNA
methylation modifications during in-utero periods of
developmental plasticity and later life.
We further examined epigenetic age acceleration or
deceleration during the critical prenatal exposures and in
later life. Our study highlighted epigenetic clock
deceleration in IUS-exposed compared to unexposed
samples. Prenatal exposure to hypoxic conditions has
been associated with epigenetic age deceleration [50],

AGING

alterations in immune and inflammatory responses,
developmental delay and cognitive decline in later life
[51]. In ALT, we observed age acceleration in males
compared to females. This is in line with previously
reported age acceleration in males over females
corresponding with higher all-cause male mortality [12,
23, 51]. We also observed a suggestive trend in ALT for
more recent smoking driving epigenetic age acceleration
suggesting that smoking cessation could improve
respiratory and lung health through modulation of lung
aging pathways, a finding of potential public health
relevance further supporting efforts to curb inhalational
exposures starting early in life.

future studies to advance our understanding of ageassociated epigenetic programming and aid development
of more sensitive lung based epigenetic age estimator.
From a public health standpoint, considering overlapping
developmental and aging pathways as potential targets
for future interventions early in life may have relevance
to curb the incidence of complex chronic diseases with
the aging of the global population. Our study combines
aging and epigenetic signatures and may constitute a
system to promote lung health and longevity by
evaluating age-modifying interventions across the life
course.

MATERIALS AND METHODS
These findings suggest two plausible aging mechanisms
[22]: (i) disruption to the aging processes may begin
before birth, and (ii) certain prenatal exposures might
increase/decrease
the
disease
risks
through
perturbations in aging pathways as a defense or
adaptation mechanism. In accordance with this
hypothesis, decreased epigenetic age was associated
with longevity in supercentenarians and their offspring
[52] but also cerebroplacental ratio, a marker for fetal
adaption to hypoxic conditions and adverse pregnancy
outcome [50].
We acknowledge that our study also has limitations
including the sample sizes of the lung datasets, paucity of
longitudinal lung tissue data, limited phenotype data
including race, geography, socioeconomic status in the
fetal lung dataset and potential residual confounding by
cellular heterogeneity associated with the lung samples
even after surrogate variable adjustment. Evidence of high
genomic inflation, despite adjusting for confounders as we
have in this study, has also been observed and discussed
frequently in other age EWAS studies and in principle
could be used as a marker of development and biological
age [11, 53, 54]. Moreover, limited association in fetal
and adult lung tissue with the epigenetic clock metrics
could be due to lack of a true association or the
consideration that a lung specific clock would perform
better, given the richness of the age associated EWAS
findings.
However,
investigating
age-associated
methylation signatures using a robust analytical
framework, in unrelated fetal and adult lung tissue
samples with a broader age range including critical stages
of development as well as adulthood, strengthens our
study. Of note, it is unlikely that one particular omic-type
or few genetic variants could lead to complex diseases of
lung. Therefore, integrative omics analyses with larger
sample sizes would mostly support future sensitivity or
sex-stratified analyses and contribute to the greatest extent
in identifying causal genes and pathways.
In summary, our findings point to age-related differential
methylation that may serve as a starting point for similar
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Study samples
Fetal lung DNA samples (n=78, 42 exposed to in utero
maternal cigarette smoke (IUS), 36 non-IUS-exposed)
were isolated from discarded tissue from 57-122 days of
gestation as previously described [29, 55]. We
performed genome-wide methylation profiling on these
samples using the Illumina HumanMethylation450
BeadChip. Fetal sex was confirmed using unique Y
chromosome microarray probes and verified using X
and Y chromosome methylation. IUS exposure was
assessed by measuring placental cotinine concentrations
[56]. Exposure was treated as a dichotomous variable
(1/0 with 1=exposed), with levels of cotinine < 7.5 ng/g
considered as unexposed and levels of cotinine >
7.5 ng/g as exposed, though we also assessed the
continuous cotinine variable. Approval was obtained
from the Partners Human Research Committee
Institutional Review Board in Boston, MA.
We used our previously published [57] adult lung tissue
(ALT) dataset, from the Adult Lung Tissue study
(n=160; 114 COPD cases, 46 subjects without COPD)
to investigate age-associated differential methylation in
adulthood. Genetic data was available for a subset of
these samples. This led to removal of eight samples
from the fetal lung dataset and 11 samples from the
ALT dataset for whom we could not calculate ancestry
principal components due to unavailability of the data.
This applied to all the epigenome-wide association
(EWAS) models.
Epigenome-wide age association and statistical
analyses
The proportion of DNA methylation at any CpG site
reported as the Illumina beta (β)-value is defined as the
ratio between methylated signal intensity and total
probe signal intensity of methylated and un-methylated
signal. A β-value ranges between 0 and 1 where 0 is
considered an un-methylated CpG site and a value
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approaching 1 is considered a completely methylated
CpG site. For biological interpretation purposes, we
used beta-scale for all models [58]. Normalization and
preprocessing were performed in Bioconductor [59]
package Minfi [60]. We evaluated site based differential
methylation (outcome) by age in both fetal lung and
adult lung datasets with linear regression using limma
[61] with correction for multiple testing using
Benjamini-Hochberg method. We accounted for the
following available covariates from the fetal lung data:
IUS-exposure to cotinine (0: unexposed as reference, 1:
exposed subjects) and sex (male/female with female as
reference) and sample plate and sentrix position as
technical covariates. Correcting for sentrix position
accounts for the positional effects of the samples on the
array [62]. For adult lung data, we included the
following
covariates:
COPD
disease
status
(cases/subjects without COPD as reference), sex
(male/female as reference), race (white as reference
versus black and others), pack-years (continuous) and
sample plate as a technical covariate. The models
evaluating age-associated differential methylation were
further tested with interaction terms to assess effect
modification by smoke exposure and sex. Ancestry
composition was estimated from genetic data using the
TRACE program (fasT and Robust Ancestry Coordinate
Estimation) as implemented in the LASER package:
(http://csg.sph.umich.edu/chaolong/LASER/) [63]. For
the fetal and ALT datasets, we adjusted for genetic
confounding using the first three (12.3%) and two
(8.3%) principal components (PCs) respectively that
explained most variability in the data. PCs did not reveal
any confounding by row and column for the ALT dataset
so sentrix position was not included in the model.
Additionally, we accounted for unknown technical
confounders in the fetal lung dataset such as observed
due to cell-type heterogeneity using supervised version
of surrogate variable analysis (s-sva) [64].
Differentially methylated positions (DMPs) were
categorized as hyper- or hypo-methylated with a unit
increase in chronological age (per day for fetal lung and
per year for adult lung dataset). We further evaluated
age-related differential methylation for effect
modification and included interaction terms of age with
IUS-exposure (categorical variable), cotinine levels
(continuous variable) and sex in the fetal lung dataset
and pack-years, sex, COPD, time since quitting/
smoking cessation (in months) and fraction of lung
voxels with low attenuation areas at less than -950
Hounsfield Units (LAA-950) to assess emphysema in the
adult lung dataset. For main effects, we used a False
Discovery Rate (FDR) of less than or equal to 0.05 and
for interaction results, we relaxed thresholds for
exploration and used an FDR of 10% (FDR<0.10). CpG
sites were mapped to genes within which they were
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located using Human Genome build: GRCh37/hg19 and
Bioconductor annotation package: IlluminaHuman
Methylation450kanno.ilmn12.hg19 [65] and their gene
context annotations were provided. If the CpG sites
were not mapped to a gene, only their CpG island
annotations were provided. We identified the
overlapping age-associated differentially methylated
positions/CpGs (aDMPs) between fetal and ALT
datasets at probe level and at an FDR < 0.05. As a
sensitivity analysis, we additionally evaluated the age
associations in fetal and ALT datasets after stratifying
by IUS-exposure and COPD status respectively.
Considering aging may have a genetic component, we
further investigated the presence of methylation
quantitative trait loci (mQTLs) among these aDMPs
using the previously published methylation lung tissue
QTL results [26].
Region-based analyses was performed using the kernel
smoothing method DMRCate [66]. Differentially
methylated regions (DMRs) were calculated from log
transformed CpG values (M-values) and defined as
regions with at least two significant sites separated by a
maximal distance of 1000 base pairs at an FDR of less
than or equal to 0.05.
Enrichment of disease associations and pathway
analysis
Functional gene-set enrichment [30] and visualization of
tissue-specific gene clusters was performed for
significant aDMPs overlapping between fetal and ALT
datasets using FUMA [30]. Unique gene symbols were
mapped to Entrez IDs using Bioconductor package
org.Hs.eg.db [67]. Network representation of clusters for
the enriched gene ontology terms and pathways was
performed using AutoAnnotate [68] and EnrichmentMap
[69] apps in Cytoscape 3.7.1 [70]. Biological processes
and pathways connected by edges were retained in the
final network. Over-representation and pathway analysis
of genes annotated to overlapping sites and regions was
performed using gProfiler2 [71] package in R and
Genomic Regions Enrichment of Annotations Tool
(GREAT) [72] version 4.0.4 (http://great.stanford.edu/
public/html/) respectively.
DNAmAge and measures of epigenetic age acceleration
The Horvath clock [16] captures DNA methylation
changes in chronological age using multiple tissue types
and implies the epigenetic patterns from birth to the
current age and included lung and fetal tissues during
algorithm development. Therefore, we chose the
Horvath clock method to determine the epigenetic age
(DNAmAge) (http://labs.genetics.ucla.edu/horvath/dna
mage/) [16] for the complete set of fetal (n=78) and
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adult lung samples (n=160) and additionally
investigated differential methylation of the 353 CpG
markers that form the aging clock. We computed two
methylation-based age acceleration measures: age
acceleration difference (epigenetic age – chronological
age) and residual (linear regressing DNA methylation
age on chronological age). Using age acceleration
difference, we tested associations with IUS-exposure in
fetal lung, and lung phenotypes in ALT. For all
regression models, chronological age was included as a
covariate [16]. To keep the units comparable to the
chronological age in adult lung, post-conception age (in
days) in fetal lung dataset was converted to a negative
chronological age (in years) implying before birth:
Chronological Age (in years) = Post Conception
Age – (9*30)/365. In ALT dataset, correlation of
epigenetic age acceleration with time since smoke
cessation/quitting (in months) and LAA-950 was
performed using Pearson correlation test. A positive
difference between calculated epigenetic age and
chronological age was considered accelerated aging and
a negative difference decelerated aging.

surrogate variable analysis; GREAT: Genomic Regions
Enrichment of Annotations Tool; DNAmAge: DNA
methylation age; EWAS: epigenome-wide association
study; mQTLs: methylation quantitative trait loci;
SNORA/snoRNAs: small nucleolar RNAs; scaRNAs/
SCARNA: small cajal body-specific RNAs; MSigDB:
The Molecular Signatures Database; IPF: idiopathic
pulmonary fibrosis; VEGFA-VEGFR2: Vascular
Endothelial Growth Factor A-Vascular endothelial
growth factor receptor 2.
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SUPPLEMENTARY MATERIALS
Supplementary Figures

Supplementary Figure 1. Q-Q plot for fetal (left panel) and adult lung tissue (right panel) dataset.

Supplementary Figure 2. Volcano plot depicting the effect size on x-axis and – log10P-Value on the y-axis. The blue colored dots
are the CpG sites at an FDR adjusted P-Value of 0.05. (A) Fetal lung dataset. Gray line represents the cut-off for the age-associated DMPs at
the Bonferroni threshold of 1.43×10-7. Highlighted CpG sites as red dots and associated genes are at an absolute regression coefficient
threshold (effect size) of 0.01. (B) Adult lung tissue (ALT) dataset. Gray line represents the cut-off for the age-associated DMPs at the
Bonferroni threshold of 1.43×10-7. Highlighted CpG sites as red dots and associated genes are at an absolute regression coefficient (effect
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size) threshold of 0.005. CpG sites colored green are those that passed the effect size threshold, however were not significant. Legend
abbreviations: Black dots as NS, not significant; Blue dots as p-value: age-associated DMPs at FDR<0.05; Red dots as p-value and regression
coefficient, represented by difference in methylation with per day increase in age in fetal lung and per year increase in ALT dataset.

Supplementary Figure 3. Age-associated differential methylation of cg16867657 located within ELOVL2 gene promoter for fetal lung (A)
and adult lung tissue (B) datasets.
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Supplementary Figure 4. Gene-set enrichment analysis for the genes annotated to the hyper-methylated age-associated
DMPs overlapping between fetal and adult lung tissue datasets using curated gene-sets and transcription factor targets
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obtained from MsigDB. (A) Enrichment based on Chemical and Genetic perturbation gene-sets (MsigDB). As an example:
BENPORATH_EED_TARGETS signify genes identified by ChIP as targets of the Polycomb protein embryonic ectoderm development (EED)
[GeneID=8726] in human embryonic stem cells. This protein mediates repression of gene activity through histone deacetylation and may act
as a regulator of integrin function. (B) Enrichment based on GO molecular function gene-sets (MsigDB) (C) Enrichment based on gene-sets
from TF targets (MsigDB). As an example, OCT1_04 signifies genes having at least one occurrence of the transcription factor-binding site (v7.4
TRANSFAC) in the regions spanning up to 4 kilo-bases around their (TSS) transcription starting sites.

Supplementary Figure 5. Scatter plot of correlation between chronological age on x-axis and estimated DNAmAge (in years)
on y-axis. Red: IUS-exposed fetal lung samples and COPD cases, Blue: Unexposed samples and controls respectively in fetal lung (A) and
adult lung tissue (B) datasets. For fetal lung datasets, chronological age in days post conception was also converted to years (refer the paper
for details), therefore x-axis represents before birth chronological age in negative.
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Supplementary Tables
Please browse Full Text version to see the data of Supplementary Tables 1–11.

Supplementary Table 1. Differentially methylated CpGs associated with age in the fetal lung tissue dataset (94,834
CpGs; FDR adjusted P-Value < 0.05).
Supplementary Table 2. Differentially methylated CpGs associated with age in the adult lung tissue dataset (2,217
CpGs; FDR adjusted P-Value < 0.05).
Supplementary Table 3. Fetal age-associated differentially methylated positions (DMPs) overlapping with adult lung
tissue (244 CpGs at FDR<0.05), sorted by column J (FDR adjusted P-value for the overall fetal lung analysis).
Supplementary Table 4. Overlapping age-associated differentially methylated positions (aDMPs) with previously
published lung tissue methylation quantitative trait loci (mQTLs) in cis (67 unique CpGs annotated to 44 unique
genes, line 2) and trans (17 unique CpGs annotated to nine unique genes, line 1915).
Supplementary Table 5. Differentially methylated regions (DMRs) between fetal with adult lung tissue datasets
based on overlapping genes (878 regions at Stouffer's FDR<0.05, sorted by significance in fetal lung data).
Supplementary Table 6. Summary statistics (number of CpGs) for the evaluated epigenome-wide age associations
and their effect modification by phenotypes in the fetal and adult lung tissue.
Supplementary Table 7. Differentially methylated CpGs with effect modification by age*sex interactions in fetal
(n=3) and adult lung (n=47) dataset (FDR Adjusted P-Value < 0.10).
Supplementary Table 8. Differentially methylated CpGs with effect modification by age*pack-years interactions
(exposure to cigarette smoke; main predictor: age*pack-years) in adult lung tissue dataset (n=11; FDR adjusted PValue<0.10).
Supplementary Table 9. Gene enrichment analysis for the genes annotated to the overlapping hyper (210 CpGs, 120
genes) and hypo-methylated (five CpGs, five genes) age-associated DMPs between fetal and adult lung dataset (144
unique genes) using gProfiler2.
Supplementary Table 10. Functional enrichment of age-associated hyper-methylated DMPs in both fetal and adult
lung tissue datasets amongst differentially expressed genes in 54 GTEx tissues (sorted by FDR adjusted P-Value).
Supplementary Table 11. Region-based enrichment analysis using GREAT server for Fetal lung (row 4) and adult lung
(row 119) tissue differentially methylated regions (DMRs) with overlapping genes.
Supplementary Table 12. Association between epigenetic age acceleration and
adult lung tissue dataset phenotype: recent smoke cessation stratified by sex: in
females and males.
Age acceleration
Multivariate
model
predictors
Females
months-quit
Males
months-quit

Estimate (95% CI)
-0.01 (-0.02, 0.001)
Estimate (95% CI)
-0.01 (-0.02, 0.01)

P-value
0.068
P-value
0.3

Note: Multivariate models were residualized for chronological age and were additionally
adjusted for race, pack-years, LAA-950 and technical covariate plate.
Abbreviations: CI, confidence interval; percentage of low attenuation areas at less than 950 Hounsfield Units (LAA-950).
Missing data: Time sine quitting data (months) was missing for 1 subject without COPD.
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